Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
0.142
-0.003 (-2.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
COEP Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 27 | 30 | 125 | 17 | - | |
| Market Cap Growth | -78.86% | -10.53% | -76.04% | 637.84% | - | - | |
| Enterprise Value | 6 | 26 | 26 | 128 | 17 | - | |
| Last Close Price | 0.14 | 0.78 | 1.53 | 10.00 | 10.19 | - | |
| PS Ratio | - | - | - | 1662.91 | 549.50 | - | |
| PB Ratio | 1.17 | 32.85 | 6.71 | 53.06 | -3.29 | - | |
| P/TBV Ratio | 1.48 | 32.85 | 6.71 | 53.06 | - | - | |
| EV/Sales Ratio | - | - | - | 1701.11 | 541.40 | - | |
| Debt / Equity Ratio | 0.36 | 1.50 | 0.46 | 1.74 | -0.41 | 0.46 | |
| Asset Turnover | - | - | - | 0.02 | 0.03 | 0.02 | |
| Quick Ratio | 0.33 | 0.50 | 1.75 | 0.79 | 0.04 | 0.51 | |
| Current Ratio | 0.40 | 0.59 | 1.81 | 0.79 | 0.04 | 0.51 | |
| Return on Equity (ROE) | -338.06% | -807.49% | -1104.48% | - | - | - | |
| Return on Assets (ROA) | -103.27% | -215.14% | -291.15% | -248.48% | -451.53% | -197.11% | |
| Return on Capital (ROIC) | -140.72% | -314.28% | -330.28% | -519.93% | - | -2216.16% | |
| Earnings Yield | -199.74% | -79.54% | -125.73% | -10.78% | -54.17% | - | |
| FCF Yield | -118.70% | -27.08% | -12.97% | -3.60% | -18.55% | - | |
| Buyback Yield / Dilution | -68.81% | -79.70% | -30.98% | -79.11% | -18.53% | -1.63% | |
| Total Shareholder Return | -68.81% | -79.70% | -30.98% | -79.11% | -18.53% | -1.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.